1,038 results found

This post explores the National Pharmaceutical Pricing Authority's powers of price control and monitoring on the Indian medical device industry against the backdrop of India's drive towards an ‘Atmanirbhar Bharat.'

Welcome to the June 2024 edition of our Lifesciences and Healthcare Newsletter. This issue covers recent updates and regulatory changes in India's lifesciences and healthcare sectors

The Ministry of Ayurveda, Yoga and Naturopathy, Unani, Siddha and Homeopathy (AYUSH) vide notification G.S.R. 1230(E) on December 21, 2018 ...

This IP newsletter covers categories of updates relating to Legal Updates, Industry Spotlight, Case Studies and Precedents, Practical Insights for IP Professionals, Upcoming Events and Webinars, and Spotlight on Innovation.

The last quarter of 2019 has been more about beginnings rather than endings. The hot button issue of e-pharmacy regulation has made a comeback to the forefront of regulatory discourse while a new issue

The European Medicines Agency's (EMA) Committee for Medicinal Products for Human Use (CHMP) has recommended six medicines for approval, including one orphan medicine, at its March 2018 meeting.

The Legal Metrology (Packaged Commodities) Rules, 2011 ("Packaging Rules") regulate pre-packaged commodities in India and inter – alia mandate certain labeling requirements prior to sale of such commodities.

Doping has seemingly reached epidemic proportions in sports, jeopardizing not only the integrity of athletic competition but also raising serious ethical, health, and legal concerns. This research will examine the legal landscape of sports, specifically focusing on legal disputes stemming from doping and how they have fuelled recent international scandals.

This current edition of our Life Sciences and Healthcare Newsletter highlights key developments in the regulatory, policy and industry space that have taken place during January 2026.

Over the past two months, the developments in the healthcare and pharma industry particularly focused on extending the scope of good manufacturing practices for pharmaceutical products...

The Telecom Regulatory Authority of India ("TRAI") vide directions dated June 2, 2023, has issued directions for all the access providers to develop and deploy new Digital Consent Acquisition ("DCA") facility by August 1, 2023.

The medical device industry is, without a doubt, one of India's sunrise industries as it has consistently outshone many other industries in terms of year on year growth.

The first half of 2019 has witnessed a lot of activity in the pharma space, so much so that the e-pharmacy saga – a pressing development towards the close of 2018 - has taken a temporary backseat this year.

Rationalisation of the current 4-tiered tax rate structure into 2 rate structure with a Standard Rate of 18% and a Merit Rate of 5%.

Welcome to the December 2025 edition of our Life Sciences and Healthcare Newsletter, covering key regulatory, policy, and industry developments across the sector.

The recent controversy with respect to MNC Giant Nestle's Maggie noodles across the country has once again opened the Pandora box with respect to dual safety standards being followed by the MNC food company in the Country.